| Record ID | ia:kitabletsimporta00unse |
| Source | Internet Archive |
| Download MARC XML | https://archive.org/download/kitabletsimporta00unse/kitabletsimporta00unse_marc.xml |
| Download MARC binary | https://www.archive.org/download/kitabletsimporta00unse/kitabletsimporta00unse_meta.mrc |
LEADER: 01422cam 2200301Ia 4500
001 5298112
005 20190308001626.0
008 060725s2006 ilu s000 0 eng d
035 $a(OCoLC)ocm70689095
040 $aSPI$cSPI
092 $a616.44$bIMPO, 2006
049 $aUIUU
245 00 $aKI tablets :$bimportant information on the use of potassium iodide (KI) tablets.
246 30 $aPotassium iodide (KI) tablets
260 $aSpringfield, Ill. :$bIllinois Emergency Management Agency, Bureau of Nuclear Facility Safety,$c[2006]
300 $a1 folded sheet (6 p.) ;$c22 x 28 cm. folded to 22 x 10 cm.
500 $aCaption title.
500 $a"IISG104-200-6/06."
520 1 $aKI is a non-prescription drug used to provide a "loading dose" of stable iodine to the thyroid when there is a risk that an individual might be exposed to a potentially harmful quantity of radioactive iodine.
650 0 $aPotassium iodide$xTherapeutic use$zIllinois.
650 0 $aThyroid gland$xDiseases$zIllinois$xPrevention.
650 0 $aIodides$xIsotopes$xToxicology$zIllinois.
650 0 $aRadiation-protective agents$zIllinois.
710 1 $aIllinois.$bEmergency Management Agency.
710 1 $aIllinois.$bBureau of Nuclear Facility Safety.
994 $aC0$bUIU
955 $bark:/13960/t8ff8445d$qkitabletsimporta00illi$v
856 41 $3Full text - HathiTrust Digital Library$uhttp://hdl.handle.net/2027/uiuo.ark:/13960/t8ff8445d